In March 2025, the company announced new programs to get a direct-to-customer offering of its Wegovy weight loss drug. The company founded a whole new pharmacy, named NovoCare, which would cost prospects $499 a month for access to the drug, below half the cost of the drug as a result of other pharmaceutical distribution networks.[53]Incorporate the